A Study of Apabetalone in Subjects With Long -COVID
A Study of Apabetalone in Subjects With Long -COVID
Recruiting · NCT06590324 · Registry updated 2025-04-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Apabetalone in Subjects With Long -COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 / Phase 3 | 2025-04-18 | NCT06590324 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Resverlogix Corp | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Al Kuwait Hospital | Dubai | United Arab Emirates | 1 |
| MNGHA- King Abdulaziz Hospital | Al Mubarraz | Saudi Arabia | 1 |
| The Speciality Hospital | Amman | Jordan | 1 |